Related Experiment Video
Updated: Apr 21, 2026
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
Brain Alterations Linked to the MPTP Mouse Model of Parkinson's Disease Uncovered by Diffusion Kurtosis Imaging and
Ajay Modi1,2, Sheetal Maria1,2, Jana Ruda-Kucerova3
1Center for Translational Medicine, International Clinical Research Centre, St. Anne's University Hospital Brno, Czech Republic.
Aims:
This study employed diffusion kurtosis imaging (DKI) and proton magnetic resonance spectroscopy (1H-MRS) on an MPTP-induced mouse model of Parkinson's disease (PD) to examine microstructural changes linked to neuroinflammation and neurodegeneration.
Methods:
MPTP (20 mg/kg, i.p.) was given for 4 days, and behavioral assessment, MRI imaging, and immunohistochemistry were performed at 24 h and 72 h after last MPTP treatment.
Results:
At 24 h, DKI showed higher diffusivity metrics in the hippocampus and thalamus, while 1H-MRS identified reduced Glu/tCr and Glx/tCr ratios in the striatum of MPTP-treated mice compared to saline-treated mice. Behavioral tests at 72 h revealed motor impairment and DKI showed increased diffusivity in the somatosensory cortex, thalamus, and striatum in MPTP-treated mice. Notably, at 72 h, the hippocampus showed partial recovery in diffusivity, suggesting adaptive changes or partial restoration. Higher diffusivity was observed in the cortex, striatum, and thalamus in MPTP-treated mice. Furthermore, 1H-MRS detected a higher Tau/tCr in the striatum, while in the hippocampus, lower Gln/tCr and NAA/tCr and higher Cho/NAA were observed at 72 h in MPTP-treated mice, indicating persistent neuronal death and membrane deterioration. Immunofluorescence staining at 72 h confirmed these findings, showing a decrease in NeuN+ neurons and an increase in GFAP+ glial cells in the striatum and hippocampus, indicating neurodegeneration and gliosis. Additionally, MPTP caused a loss of dopaminergic neurons in the substantia nigra and striatum, which likely explains the higher diffusivity shown by DKI.
Conclusion:
These findings demonstrate DKI and 1H-MRS are sensitive, non-invasive modalities for detecting and monitoring neurodegenerative microstructural and neurochemical changes, enhancing the understanding of PD-related pathology and progression.
Insights
Diffusion kurtosis imaging (DKI) and proton magnetic resonance spectroscopy (1H-MRS) detect neuroinflammation and neurodegeneration in a Parkinson
Area of Science:
- Neuroscience
- Biomedical Imaging
- Neurodegenerative Diseases
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms and progressive loss of dopaminergic neurons.
- Neuroinflammation and neurochemical alterations are key pathological features of PD, but their early detection remains challenging.
Purpose of the Study:
- To investigate the utility of diffusion kurtosis imaging (DKI) and proton magnetic resonance spectroscopy (1H-MRS) for detecting microstructural and neurochemical changes in an MPTP-induced mouse model of PD.
- To correlate imaging findings with neuroinflammation, neurodegeneration, and motor deficits.
Main Methods:
- MPTP (20 mg/kg) was administered to mice for 4 days.
- Behavioral tests, DKI, 1H-MRS, and immunohistochemistry were performed at 24 and 72 hours post-treatment.
- Analysis focused on diffusivity metrics, metabolite ratios, neuronal counts (NeuN+), and glial cell activation (GFAP+).
Main Results:
- DKI revealed increased diffusivity in the hippocampus, thalamus, and striatum, correlating with motor impairment and dopaminergic neuron loss.
- 1H-MRS showed altered ratios of glutamate (Glu/tCr), glutamine (Glx/tCr), taurine (Tau/tCr), N-acetylaspartate (NAA/tCr), and choline (Cho/NAA) in the striatum and hippocampus.
- Immunohistochemistry confirmed neurodegeneration (decreased NeuN+) and gliosis (increased GFAP+) in affected brain regions.
Conclusions:
- DKI and 1H-MRS are sensitive, non-invasive tools for detecting and monitoring neurodegenerative and neuroinflammatory changes in PD models.
- These imaging modalities enhance the understanding of PD pathology and disease progression.
- Findings support the use of DKI and 1H-MRS for preclinical research and potential clinical applications in Parkinson's disease.
